PPARγ but not PPARα Ligands Are Potent Repressors of Major Histocompatibility Complex Class II Induction in Atheroma-Associated Cells
- 22 February 2002
- journal article
- other
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 90 (3) , 356-362
- https://doi.org/10.1161/hh0302.104924
Abstract
Peroxisome proliferator-activated receptors (PPARs) are essential in glucose and lipid metabolism and are implicated in metabolic disorders predisposing to atherosclerosis, such as diabetes and dys...Keywords
This publication has 34 references indexed in Scilit:
- 15‐Deoxy‐Δ12,14‐PGJ2, but not troglitazone, modulates IL‐1β effects in human chondrocytes by inhibiting NF‐κB and AP‐1 activation pathwaysFEBS Letters, 2001
- A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and AtherogenesisMolecular Cell, 2001
- Are Immunological Mechanisms Relevant for the Development of Atherosclerosis?Clinical Immunology, 1999
- Activation of Proliferator-activated Receptors α and γ Induces Apoptosis of Human Monocyte-derived MacrophagesJournal of Biological Chemistry, 1998
- PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDLCell, 1998
- Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγCell, 1998
- Activation of the MHC Class II Transactivator CIITA by Interferon-γ Requires Cooperative Interaction between Stat1 and USF-1Published by Elsevier ,1998
- Regulation of MHC Class II Expression by Interferon-γ Mediated by the Transactivator Gene CIITAScience, 1994
- Localization of T lymphocytes and macrophages in fibrous and complicated human atherosclerotic plaquesAtherosclerosis, 1988
- Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis.Journal of Clinical Investigation, 1985